Dashboard
Manage Tickers

EOLSEvolus, Inc.

Nasdaq evolus.com


$ 13.15 $ -0.11 (-0.83 %)    

Thursday, 09-May-2024 15:08:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.04 $ 0.62 (0.14 %)
DIA $ 393.88 $ 3.74 (0.96 %)
SPY $ 519.74 $ 2.30 (0.44 %)
TLT $ 90.70 $ 0.66 (0.73 %)
GLD $ 216.27 $ 1.57 (0.73 %)
$ 13.26
$ 13.11
$ 12.91 x 100
$ 13.17 x 100
$ 12.89 - $ 13.25
$ 7.07 - $ 15.43
1,264,863
na
779.65M
$ 1.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-08-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-04-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 03-20-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-29-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-evolus-maintains-27-price-target
HC Wainwright & Co. Reiterates Buy on Evol...
05/08/2024 19:10:28

HC Wainwright & Co. analyst Douglas Tsao reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $27 price target.

needham-reiterates-buy-on-evolus-maintains-22-price-target
Needham Reiterates Buy on Evolus, Maintain...
05/08/2024 10:53:39

Needham analyst Serge Belanger reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $22 price target.

evolus-q1-2024-adj-eps-008-beats-010-estimate-sales-59333m-beat-57321m-estimate
Evolus Q1 2024 Adj EPS $(0.08) Beats $(0.1...
05/07/2024 20:39:44

Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.10) by 20 ...

evolus-announces-publication-of-safety-and-duration-data-from-phase-2-study-for-extra-strength-40u-formulation-of-jeuveau
Evolus Announces Publication Of Safety and...
04/17/2024 20:13:03

The article published in Aesthetic Surgery Journal supports safety and duration of effect for temporary improvement in the appe...

needham-reiterates-buy-on-evolus-maintains-22-price-target
Needham Reiterates Buy on Evolus, Maintain...
04/10/2024 10:47:23

Needham analyst Serge Belanger reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $22 price target.

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 21:33:35

evolus-reports-pricing-of-50m-offering-of-common-stock
Evolus Reports Pricing Of $50M Offering Of...
03/11/2024 11:03:44

In addition, Evolus has granted the underwriters a 30-day option to purchase up to an additional 533,100 shares of common stock...

stifel-reiterates-buy-on-evolus-raises-price-target-to-25
Stifel Reiterates Buy on Evolus, Raises Pr...
03/08/2024 15:36:41

Stifel analyst Annabel Samimy reiterates Evolus (NASDAQ:EOLS) with a Buy and raises the price target from $23 to $25.

needham-reiterates-buy-on-evolus-maintains-22-price-target
Needham Reiterates Buy on Evolus, Maintain...
03/08/2024 12:08:30

Needham analyst Serge Belanger reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $22 price target.

mizuho-maintains-buy-on-evolus-raises-price-target-to-23
Mizuho Maintains Buy on Evolus, Raises Pri...
03/08/2024 12:07:21

Mizuho analyst Uy Ear maintains Evolus (NASDAQ:EOLS) with a Buy and raises the price target from $20 to $23.

hc-wainwright--co-reiterates-buy-on-evolus-maintains-27-price-target
HC Wainwright & Co. Reiterates Buy on Evol...
03/08/2024 11:56:18

HC Wainwright & Co. analyst Douglas Tsao reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $27 price target.

evolus-sees-fy24-total-net-revenues-255m-265m-vs-26117m-est
Evolus Sees FY24 Total Net Revenues $255M-...
03/07/2024 22:08:55

recap-evolus-q4-earnings
Recap: Evolus Q4 Earnings
03/07/2024 21:50:23

evolus-q4-2023-gaap-eps-0210-misses-0200-estimate-sales-60999m-beat-60056m-estimate
Evolus Q4 2023 GAAP EPS $(0.210) Misses $(...
03/07/2024 21:46:28

Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.210) per share which missed the analyst consensus estimate of $(0.200) by...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

earnings-outlook-for-evolus
Earnings Outlook For Evolus
03/06/2024 15:02:19

hc-wainwright--co-reiterates-buy-on-evolus-maintains-27-price-target
HC Wainwright & Co. Reiterates Buy on Evol...
03/01/2024 19:15:39

HC Wainwright & Co. analyst Douglas Tsao reiterates Evolus (NASDAQ:EOLS) with a Buy and maintains $27 price target.

evolus-announces-results-from-european-head-to-head-filler-trial-european-lift-study-met-the-primary-endpoint-of-non-inferiority
Evolus Announces Results From European Hea...
03/01/2024 13:32:25

  Evolus dermal filler product (Evolysse™/Estyme® Lift) demonstrates statistical superiority at 3 and 6 months compared to Res...

why-panbela-therapeutics-shares-are-trading-lower-by-65-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Panbela Therapeutics Shares Are Tradin...
01/29/2024 19:09:05

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of...

sofi-technologies-posts-q4-earnings-joins-cardlytics-mcgrath-rentcorp-and-other-big-stocks-moving-higher-on-monday
SoFi Technologies Posts Q4 Earnings, Joins...
01/29/2024 15:31:22

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOF...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION